Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mega Genomics Limited ( (HK:6667) ) has issued an announcement.
Mega Genomics Limited has brought forward its 2026 annual general meeting, rescheduling it from 26 June to 21 May in Hong Kong. The company said all other information previously disclosed with its 31 March 2026 annual results remains unchanged, and a circular with full AGM details and proxy materials will be issued to shareholders in due course.
To align with the new AGM date, Mega Genomics has also adjusted the closure period for its register of members to 18–21 May 2026, with 21 May as the record date for voting eligibility. The change clarifies when share transfers must be lodged, ensuring investors understand the cut-off for attending and voting, and underscores the administrative precision required for shareholders to exercise their rights.
More about Mega Genomics Limited
Mega Genomics Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 6667. The company operates in the genomics sector, with a board comprising executive, non-executive and independent non-executive directors, and maintains its Hong Kong share registrar through Tricor Investor Services Limited.
The firm’s governance structure and listing status mean procedural changes to meetings and share registration are material for investors following its corporate actions and exercising voting rights.
Average Trading Volume: 7,354
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.63B
For an in-depth examination of 6667 stock, go to TipRanks’ Overview page.